PROM2 and cancer: Mechanistically, reduced iron concentration in cells caused by PROM2 could protect tumors from ferroptosis, and the inhibition of PROM2 transcription sensitizes drug-resistant cancer cells to ferroptosis inducers (Brown et al., 2021).